[Pharmacogenetic contribution to individualized treatment. Severe adverse effects can be avoided] Läkartidningen [Lakartidningen] Journal article

Title	[Pharmacogenetic contribution to individualized treatment. Severe adverse effects can be avoided]
Author(s)	Eliasson E
Institution	Klinisk farmakologi, institutionen för laboratoriemedicin, Karolinska institutet. erik.eliasson@ki.se
Source	Lakartidningen 2008 May 28-Jun 3; 105(22):1644-5.
MeSH	Dideoxynucleosides Drug Hypersensitivity HLA-B Antigens Humans Pharmaceutical Preparations Pharmacogenetics Risk Factors Safety
Language	swe
Pub Type(s)	Journal Article
PubMed ID	18590003

Advertise on this site.